Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Says PCCPs Are Possibility For Sterilization Changes

Executive Summary

During its third EtO town hall, the CDRH brought up the possibility of approving predetermined change control plans for device sterilization changes. 

You may also be interested in...



Vaporized Hydrogen Peroxide Moved To Established Category A, And Other Updates From FDA’s EtO Town Hall

A US FDA town hall explained the vaporized hydrogen peroxide category update and set the stage for a series of meetings to come.

What A Difference A Year Makes; AI Makes The A-List

The US FDA’s Center for Devices and Radiological Health has announced the guidance documents it plans to focus on in fiscal year 2024, and this time, AI devices make the cut.

Expert: Cybersecurity Requirements In Omnibus Bill Will Provide Visibility For Industry

New cybersecurity regulations passed as part of the year-end omnibus bill included software bills of materials (SBOMs) which will provide visibility to manufacturers and regulators.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT154418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel